MC38-hCD24/hPD-L1

Export PDF

Strain Information

Cell Line

MC38-hCD24/hPD-L1

Cat. NO.

NMC-230052

Model Description

The MC38-hCD24/hPD-L1 cell line is the MC38 colon cancer tumor cell line expressing human CD24 gene and human PD-L1 gene.

Strain State

Validation of tumorigenic capacity completed

Validation Data

image.pngFig.1 CD24 and PD-L1 expression in MC38-hCD24/hPD-L1 cell line

image.png

Fig.2 Tumor growth curve of MC38-hCD24/hPD-L1 syngeneic model

image.png

Fig.3 Body weight change of MC38-hCD24/hPD-L1 syngeneic model

image.png


Fig.4 The expression of hCD24 and hPD-L1 in humanized modified tumors by FACS



Related Strain(s)

MC38-hPD-L1/hCLAUDIN 18.2
Cell Line：

MC38-hPD-L1/hCLAUDIN 18.2

Cat. NO.：NMC-230113
CT26-hPD-L1/hCLAUDIN 18.2
Cell Line：

CT26-hPD-L1/hCLAUDIN 18.2

Cat. NO.：NMC-230112
3T3-L1-Hif3a-KO
Cell Line：

3T3-L1-Hif3a-KO

Cat. NO.：NMC-230111
CT26-hIL13RA2
Cell Line：

CT26-hIL13RA2

Cat. NO.：NM-S24A-TM30
B16F10-hPDL1-Sirpa-KO
Cell Line：B16F10-hPDL1-Sirpa-KO
Cat. NO.：NMC-230067

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more